Accutane Blood Test: What to Monitor on Isotretinoin

Medically reviewed content. Last updated: February 2026.

Isotretinoin — known by the brand names Accutane (US) and Roaccutane (UK) — is the most effective treatment for severe and treatment-resistant acne. It works by dramatically reducing sebum production, shrinking oil glands, and addressing the root causes of cystic and nodular acne that topical treatments and antibiotics cannot resolve.

But isotretinoin is not a casual prescription. It is a powerful retinoid with well-documented effects on your liver, lipid metabolism, and blood cell production. In the UK, only dermatologists can prescribe it, and regular blood monitoring is mandatory throughout treatment. Your dermatologist will not continue your prescription without up-to-date blood results.

This guide explains exactly which blood tests are required, why each one matters, what your results should look like, and when abnormal values mean treatment needs to be paused or stopped.

Why Are Blood Tests Required on Accutane?

Isotretinoin is metabolised by the liver, and its pharmacological effects extend well beyond the skin. While it is clearing your acne, it is simultaneously altering lipid metabolism, placing additional metabolic demand on the liver, and affecting blood cell production. Blood tests serve three essential purposes during treatment:

1. Establishing a Safe Baseline

Before prescribing isotretinoin, your dermatologist needs to confirm that your liver, lipids, and blood counts are within normal limits. Pre-existing conditions — such as elevated liver enzymes from fatty liver disease, high cholesterol, or a lipid disorder — may make isotretinoin unsuitable or require a lower starting dose and closer monitoring.

2. Detecting Drug-Induced Changes Early

Isotretinoin can elevate liver enzymes and triglycerides within the first few weeks of treatment. Most changes are mild, but catching a rapid rise early allows your dermatologist to reduce the dose before values reach a dangerous threshold. Without monitoring, a treatable lipid increase could progress to levels that risk acute pancreatitis.

3. Pregnancy Prevention

Isotretinoin is one of the most potent teratogens in clinical use. Even a single dose during pregnancy can cause severe birth defects affecting the brain, heart, and face. In the UK, the Pregnancy Prevention Programme (PPP) — managed by the MHRA — requires medically supervised pregnancy tests before, during, and after treatment for all patients who could become pregnant.

Accutane Blood Test Schedule

The UK product information for isotretinoin recommends monitoring liver enzymes and fasting serum lipids at baseline, one month into treatment, and at regular intervals thereafter. In practice, most UK dermatologists follow a schedule close to the one below, though the exact frequency may vary based on your individual risk factors and response.

Note on fasting: Lipid tests require a 12-hour fast for accurate results. Schedule your blood draw for the morning before eating. Water is fine.

Note on pregnancy testing: Under the UK Pregnancy Prevention Programme, patients who could become pregnant must have a medically supervised pregnancy test within 3 days before each prescription. A final pregnancy test is required 5 weeks after discontinuing treatment. Since January 2026, the MHRA has confirmed that remote pregnancy testing with appropriate clinical oversight is acceptable.

Essential Blood Tests on Isotretinoin

The following table details every marker your dermatologist monitors, why it matters, and what abnormal values look like.

Liver Function on Isotretinoin

Isotretinoin is metabolised in the liver, and liver enzyme elevations are one of the most closely watched side effects. Here is what the research shows.

How Common Are Liver Enzyme Elevations?

Studies report that up to 15% of patients on isotretinoin experience some degree of liver enzyme (ALT or AST) elevation during treatment. However, the vast majority of these elevations are mild — typically less than 1.5 times the upper limit of normal — and are self-limiting. Clinically significant elevations (above 3x ULN) that require dose modification occur in fewer than 1% of patients, according to data published in the British Journal of Dermatology and the NIH LiverTox database.

What Happens If ALT or AST Are Elevated?

Your dermatologist will follow a stepwise approach:

1. Mild elevation (up to 2x ULN): Continue treatment at the current dose. Recheck in 2-4 weeks. Advise alcohol avoidance and dietary review.
2. Moderate elevation (2-3x ULN): Reduce the dose by 50% or pause treatment temporarily. Recheck within 2 weeks. If values normalise, restart at a lower dose.
3. Significant elevation (above 3x ULN): Pause treatment. Investigate other potential causes (alcohol, other medications, viral hepatitis). Resume at a lower dose only if values return to normal and no alternative cause is found.
4. Severe elevation (above 5x ULN) or with symptoms (jaundice, abdominal pain): Discontinue isotretinoin immediately. Urgent hepatology referral.

The good news: Isotretinoin-induced liver enzyme elevations are almost always reversible. Values typically return to baseline within 2-4 weeks of dose reduction or discontinuation. True drug-induced liver injury from isotretinoin is exceedingly rare.

Risk Factors for Liver Issues

You are at higher risk of liver enzyme elevation on isotretinoin if you:

• Consume alcohol regularly (even moderate drinking)
• Have pre-existing fatty liver disease (NAFLD)
• Are taking other hepatically metabolised medications (e.g., certain antibiotics, paracetamol regularly)
• Have a higher body weight (which may require higher isotretinoin doses relative to liver capacity)
• Are on a higher dose of isotretinoin (above 0.5 mg/kg/day)

Practical advice: Avoid or minimise alcohol throughout your isotretinoin course. The combination places a significant metabolic burden on the liver. Your dermatologist will advise on this, and it is one of the most impactful things you can do to keep your blood results clean throughout treatment.

Lipid Changes on Isotretinoin

Isotretinoin's effect on blood lipids is its most common metabolic side effect. A systematic review of lipid changes found that isotretinoin use leads to increased levels of total cholesterol, triglycerides, and LDL, while HDL levels tend to decrease. Understanding these changes — and when they become dangerous — is essential.

Triglycerides: The Primary Concern

Triglyceride elevation is the most frequent and potentially most dangerous lipid change on isotretinoin. The drug alters hepatic very-low-density lipoprotein (VLDL) metabolism, leading to increased triglyceride synthesis and reduced clearance.

What the numbers mean:

• Normal: Below 1.7 mmol/L (150 mg/dL)
• Borderline high: 1.7-2.3 mmol/L — dietary modifications advised, continue treatment with monitoring
• High: 2.3-5.0 mmol/L — consider dose reduction. Implement dietary changes (reduce refined carbohydrates, sugar, alcohol). Recheck in 2-4 weeks.
• Very high (above 5 mmol/L / 500 mg/dL): Dose reduction or discontinuation required. At this level, the risk of acute pancreatitis becomes clinically significant. This is a medical decision point — your dermatologist will either halve the dose and recheck, or stop treatment.

In practice, most patients experience a moderate triglyceride rise of 20-30% above baseline. Severe hypertriglyceridaemia above 5 mmol/L is uncommon in otherwise healthy young patients but is more likely in those with a family history of dyslipidaemia, pre-existing elevated levels, high body weight, or high alcohol intake.

Cholesterol Changes

Total cholesterol and LDL cholesterol can increase during isotretinoin treatment, while HDL may decrease. These changes are generally mild and reversible but warrant monitoring, particularly in patients with pre-existing cardiovascular risk factors.

The clinical significance is debated for most acne patients, who are typically young and otherwise healthy. However, if you have a family history of premature cardiovascular disease or familial hypercholesterolaemia, discuss this with your dermatologist before starting treatment. They may monitor your lipids more frequently or start you on a lower dose.

Dietary Steps to Manage Lipid Changes

• Reduce refined carbohydrates and added sugars — these are the primary dietary drivers of triglyceride synthesis
• Minimise or avoid alcohol entirely — alcohol independently raises triglycerides and compounds the isotretinoin effect
• Increase omega-3 fatty acid intake (oily fish, flaxseed) — omega-3s have a modest triglyceride-lowering effect
• Maintain regular physical activity — exercise improves lipid profiles broadly
• Ensure blood tests are truly fasting (12 hours) — non-fasting triglyceride levels can appear artificially elevated

Other Monitoring on Isotretinoin

Full Blood Count (FBC)

Isotretinoin can affect blood cell production, though significant haematological changes are uncommon. Your FBC monitors:

• White blood cells: Mild leucopenia (low white cell count) or neutropenia can occur. Significant drops increase infection risk.
• Red blood cells and haemoglobin: Mild anaemia is occasionally reported. If you are feeling unusually fatigued on isotretinoin, an FBC will help determine whether anaemia is contributing.
• Platelets: Thrombocytopenia (low platelets) is rare but would increase bruising and bleeding risk.

Clinically significant FBC changes are rare in isotretinoin patients. Most dermatologists include it in the baseline panel and repeat it if symptoms develop, rather than testing monthly.

Mood and Mental Health Monitoring

While not a blood test, mood monitoring is a mandatory part of isotretinoin management in the UK. The MHRA requires dermatologists to assess mental health at every follow-up appointment. Research shows that approximately 10.5% of patients experience mood changes during treatment, with the most common being depressive symptoms, anxiety, and emotional lability.

However, the relationship is nuanced. Most studies find that acne itself is a significant driver of depression and anxiety, and many patients experience improved mood as their skin clears. In a review of 247 patients aged 10-25, 88% of those who experienced mood changes saw symptoms improve to baseline while continuing treatment.

The key message: if you notice persistent low mood, increased anxiety, irritability, or any thoughts of self-harm during treatment, contact your dermatologist immediately. These symptoms are taken seriously and do not automatically mean you must stop treatment — but they require clinical assessment.

Sexual Function Monitoring

Since October 2025, the MHRA has required UK dermatologists to ask about sexual function at follow-up appointments. Reports of sexual side effects — including reduced libido and erectile dysfunction — have been documented, and importantly, some reports suggest these effects can persist after treatment ends. Your dermatologist will discuss this with you before and during treatment.

Vision and Eye Health

Isotretinoin commonly causes dry eyes and can rarely affect night vision. While no specific blood test monitors this, your dermatologist will ask about visual symptoms at each appointment. Contact lens wearers should be aware that tolerance may decrease during treatment, and lubricating eye drops may be necessary.

How Isotretinoin Is Prescribed in the UK

If you are in the UK, there are several important differences from other countries:

• Dermatologist-only prescribing. GPs cannot prescribe isotretinoin. You need a referral to a consultant dermatologist (NHS or private). In some services, specialty registrars and dermatology nurses with appropriate training can also prescribe under supervision.
• Pregnancy Prevention Programme (PPP). The UK does not use the US iPLEDGE system. Instead, the MHRA oversees a Pregnancy Prevention Programme with three patient groups: Group A (no expected pregnancy risk — less frequent pregnancy testing required), Group B (on long-acting reversible contraception — pregnancy testing at follow-up appointments), and Group C (all other patients who could become pregnant — monthly pregnancy testing plus dual contraception).
• Updated guidance (January 2026). Follow-up appointments can now be conducted remotely where appropriate, and remote pregnancy testing with clinical oversight is acceptable. The first appointment must still be in person. Healthcare professionals can now prescribe to under-18s without a mandatory second prescriber agreement, though additional safeguards have been introduced.
• Treatment duration and dosing. A typical UK isotretinoin course lasts 4-8 months at a dose of 0.5-1.0 mg/kg/day, aiming for a cumulative dose of 120-150 mg/kg. Lower doses may be used for longer durations in some cases.

When Should Isotretinoin Be Stopped Based on Blood Results?

Your dermatologist makes the final decision, but the following blood result thresholds are widely used as clinical decision points:

Reassurance: The majority of isotretinoin courses are completed without any blood test abnormality requiring dose change. A 2022 critically appraised topic published in the British Journal of Dermatology found that routine screening in otherwise healthy young patients rarely identifies clinically actionable abnormalities. The tests are still mandatory — but the odds are strongly in your favour.

Frequently Asked Questions About Accutane Blood Tests